Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Research Shows Liposomal Vitamin C Makes Skin 33% Firmer

Published: Tuesday, February 25, 2014
Last Updated: Tuesday, February 25, 2014
Bookmark and Share
Altrient® C significantly improves skins elasticity in just 4 weeks.

Abundance & Health has announced positive results of a 4 week clinical trial investigating the anti-aging skin firming properties of their lead product Altrient® C, the world’s first liposomal vitamin C gel.

The results of the trial demonstrated that participants taking Altrient C had significantly improved their skin elasticity over the 4-week period of the clinical trial, compared to those taking the placebo. Participants using Altrient C had improved skin firmness and elasticity by 32.7 percent over the same period.

After just 14 days, skin firmness and elasticity had already improved by 15.1 percent (over 1 percent a day on average). The trial tested the general skin firming properties of Altrient C, rather than just those parts of the body that lotions are commonly applied to. 100 percent of participants reported that they would switch to Altrient C in favour of their current anti-aging skincare product.

“Skin elasticity is a critical part in the visual aging process, and thousands of years of research has so far provided limited results. This research has demonstrated a clear link between the skin aging process and vitamin C via dietary supplements,” said Jonathan Orchard, Director, Abundance & Health. “However, up to 85 percent of the vitamin C contained in tablets and powders is destroyed in the digestive system. Altrient C's vitamin C is encased in a tiny bubble of protective fatty acids. This safeguards the vitamin through the harsh digestive system and the body’s absorption barriers, into the bloodstream, where it is transported through the body. This is a unique vitamin C delivery mechanism, ensuring maximum benefits. This research has shown that skin elasticity is considerably improved by this unique delivery system, ensuring that up to 98 percent of the vitamin C is absorbed straight into the bloodstream, reaching cells in the most effective way.”

The placebo-controlled trial was conducted by Aspen Clinical Research, the clinical and cosmetic industry researchers. The trial involved 60 participants with non-firm aging skin aged between 31 and 65+. 50 percent took 3 sachets of Altrient C a day for 4 weeks and 50 percent taking a placebo. Participants’ skin firmness and elasticity were measured at three points through the trial by Cutometer MPA 580, the Courage + Khazaka electronic GmbH elasticity measurement device.

After 4 weeks, 100 percent of participants who consumed Altrient C reported an overall improvement in the skin. 50 percent noticed greater hydration. 43 percent thought they looked younger. 33 percent thought their skin appeared more nourished. 100 percent would change their current anti-aging routine by not just adding Altrient C to their skin regime, but replacing all products they currently use with Altrient C.

Abundance & Health plan to run a second clinical trial for a longer period, in order to measure a peak in the skins improvement. The second trial will determine how long improvements in skin elasticity will continue, as well as how much additional improvement can be measured.

“Skin ageing is a complex process involving genetic, hormonal and environmental factors,” said Dr Sanjay Rajpara, dermatologist and cosmetic skin doctor. “Formation of free oxygen radicals is widely accepted as a pivotal mechanism leading to skin ageing. The production of free radicals increases with ageing. Vitamin C is an important part of the body’s anti oxidative defence mechanism. Although there are some studies showing this benefit in vitro, there are not many showing direct effects of vitamin C in humans. This is a good quality study showing improvement in skin elasticity in human skin over a period of 4 weeks. This product has a potential to become one of the first line products for anti-ageing.”

“At Aspen Clinical Research, a leading expert in claim substantiation, we test thousands of products every year. We conducted a 4-week trial based upon industry standard techniques to assess the skin firming capabilities of an ingested dietary supplement, Altrient C,” said Danny McCamlie, Lead Clinical Scientist and Principal Investigator at Aspen Clinical. “We found that Altrient C caused an increase in skin firmness and skin elasticity under Cutometery assessments. With an increase of 15.1 percent and 32.7 percent in skin firmness, following 2 and 4 weeks respectively, Altrient C achieved results that, in our experience, some topically applied creams fail to achieve following 8 weeks of use.”

There were some results in addition to skin firmness. Of those taking Altrient C suffering from colds and flu, 36 percent recovered in 1-2 days, and 64 percent recovered in 3 - 4 days. This was in comparison to the placebo respondents where 82 percent took 5 - 6 days to recover. In addition, all of the subjects consuming Altrient C also reported a significant increase in their energy levels.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos